Search research articles
Contact Us
Filters
Showing results (11-20 of 26) with videos related to
Page
of 3
Sort By:
International Journal of Molecular Sciences
|
May 24, 2019
Development of a Bioluminescent BRCA1-Deficient Xenograft Model of Disseminated, High-Grade Serous Ovarian Cancer
Yen Ting Shen, Lucy Wang, James C Evans, et al.
Molecular Pharmaceutics
|
May 12, 2018
BRCA Status Does Not Predict Synergism of a Carboplatin and Olaparib Combination in High-Grade Serous Ovarian Cancer Cell Lines
Yen Ting Shen, James C Evans, Gaetano Zafarana, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
December 2, 2017
Cyclodextrin-siRNA conjugates as versatile gene silencing agents
Meenakshi Malhotra, Matt Gooding, James C Evans, et al.
Journal of Pharmaceutical Sciences
|
March 19, 2021
Poly(δ-valerolactone-co-allyl-δ-valerolactone) cross-linked microparticles: Formulation, characterization and biocompatibility
Zeqing Bao, Sungmin Jung, Jack Bufton, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine
|
November 8, 2021
Turning down the heat: The case for mild hyperthermia and thermosensitive liposomes
Maximilian Regenold, Pauric Bannigan, James C Evans, et al.
Molecular Pharmaceutics
|
December 29, 2017
Ratio-Dependent Synergism of a Doxorubicin and Olaparib Combination in 2D and Spheroid Models of Ovarian Cancer
Sina Eetezadi, James C Evans, Yen-Ting Shen, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
December 12, 2022
Triggered release from thermosensitive liposomes improves tumor targeting of vinorelbine
Maximilian Regenold, Kan Kaneko, Xuehan Wang, et al.
Scientific Reports
|
May 28, 2021
Heat-activated nanomedicine formulation improves the anticancer potential of the HSP90 inhibitor luminespib in vitro
Brittany Epp-Ducharme, Michael Dunne, Linyu Fan, et al.
International Journal of Pharmaceutics
|
January 2, 2016
A novel, anisamide-targeted cyclodextrin nanoformulation for siRNA delivery to prostate cancer cells expressing the sigma-1 receptor
Kathleen A Fitzgerald, Meenakshi Malhotra, Matt Gooding, et al.
Journal of Pharmaceutical Sciences
|
March 8, 2014
Biophysical and structural characterisation of nucleic acid complexes with modified cyclodextrins using circular dichroism
Aoife M O'Mahony, Michael F Cronin, Anthony McMahon, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 26) with videos related to
Sort By:
Page
of 3
International Journal of Molecular Sciences
|
May 24, 2019
Development of a Bioluminescent BRCA1-Deficient Xenograft Model of Disseminated, High-Grade Serous Ovarian Cancer
Yen Ting Shen, Lucy Wang, James C Evans, et al.
Molecular Pharmaceutics
|
May 12, 2018
BRCA Status Does Not Predict Synergism of a Carboplatin and Olaparib Combination in High-Grade Serous Ovarian Cancer Cell Lines
Yen Ting Shen, James C Evans, Gaetano Zafarana, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
December 2, 2017
Cyclodextrin-siRNA conjugates as versatile gene silencing agents
Meenakshi Malhotra, Matt Gooding, James C Evans, et al.
Journal of Pharmaceutical Sciences
|
March 19, 2021
Poly(δ-valerolactone-co-allyl-δ-valerolactone) cross-linked microparticles: Formulation, characterization and biocompatibility
Zeqing Bao, Sungmin Jung, Jack Bufton, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine
|
November 8, 2021
Turning down the heat: The case for mild hyperthermia and thermosensitive liposomes
Maximilian Regenold, Pauric Bannigan, James C Evans, et al.
Molecular Pharmaceutics
|
December 29, 2017
Ratio-Dependent Synergism of a Doxorubicin and Olaparib Combination in 2D and Spheroid Models of Ovarian Cancer
Sina Eetezadi, James C Evans, Yen-Ting Shen, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
December 12, 2022
Triggered release from thermosensitive liposomes improves tumor targeting of vinorelbine
Maximilian Regenold, Kan Kaneko, Xuehan Wang, et al.
Scientific Reports
|
May 28, 2021
Heat-activated nanomedicine formulation improves the anticancer potential of the HSP90 inhibitor luminespib in vitro
Brittany Epp-Ducharme, Michael Dunne, Linyu Fan, et al.
International Journal of Pharmaceutics
|
January 2, 2016
A novel, anisamide-targeted cyclodextrin nanoformulation for siRNA delivery to prostate cancer cells expressing the sigma-1 receptor
Kathleen A Fitzgerald, Meenakshi Malhotra, Matt Gooding, et al.
Journal of Pharmaceutical Sciences
|
March 8, 2014
Biophysical and structural characterisation of nucleic acid complexes with modified cyclodextrins using circular dichroism
Aoife M O'Mahony, Michael F Cronin, Anthony McMahon, et al.
Page
of 3